Neoadjuvant immunotherapy for patients with resectable stage III/IV cutaneous melanoma: A Swedish retrospective real-world study (NEO-MEL).

Authors: Axel Nelson, Ellen Krabbe, Karl Björksrtöm, Braslav Jovanovic, Christian U. Blank, Gustav J. Ullenhag, Hildur Helgadottir, Lars Ny, Roger Olofsson Bagge

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e21563

Source: Full article

---

Abstract

e21563